Difference between revisions of "Template:Infobox medical condition/testcases"

From blackwiki
Jump to navigation Jump to search
imported>Paine Ellsworth
(/testcases)
imported>Plastikspork
(Remove page from Special:WantedTemplates)
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
* See also: [[:Template:Infobox medical condition/testcases]]
 
 
 
==[[Bisalbuminemia]]==
 
==[[Bisalbuminemia]]==
 
:{{q|Q4917184}} {{q|P1995}}
 
:{{q|Q4917184}} {{q|P1995}}
:{{track wikidata|P1995}}
 
 
:{{#invoke:Wikidata|getValueFromID|Q4917184|P1995|FETCH_WIKIDATA}}  
 
:{{#invoke:Wikidata|getValueFromID|Q4917184|P1995|FETCH_WIKIDATA}}  
  
Line 33: Line 30:
 
| specialty = something-with-ref<ref>{{cite web|title=Something|url=http://aaaa.com|website=AAA|accessdate=2 March 2016|date=March 1, 2011}}</ref>
 
| specialty = something-with-ref<ref>{{cite web|title=Something|url=http://aaaa.com|website=AAA|accessdate=2 March 2016|date=March 1, 2011}}</ref>
  
 +
}}
 +
==[[User:lukelahood/sandbox]]==
 +
{{testcase_table
 +
| name            = Facioscapulohumeral muscular dystrophy
 +
| synonyms        = Landouzy–Dejerine muscular dystrophy, FSHMD, FSH
 +
| image          = File:Timelapse Expression of DUX4 Protein in FSHD Cells.ogv
 +
| image_thumbtime = 34
 +
| caption        = Timelapse of DUX4 being expressed in FSHD Muscle Cells<ref name=DUX4expression>{{cite journal|last1=Rickard|first1=Amanda|last2=Petek|first2=Lisa|last3=Miller|first3=Daniel|title=Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways|journal=Hum. Mol. Genet.|date=August 5, 2015|doi=10.1093/hmg/ddv315|url=http://hmg.oxfordjournals.org/content/early/2015/08/17/hmg.ddv315.long|accessdate=September 10, 2015|pmid=26246499|pmc=4581613|volume=24|issue=20|pages=5901–14}}</ref>
 +
| pronounce      =
 +
| field          = [[Neurology]]
 +
| symptoms        = Facial weakness, scapular winging, foot drop
 +
| complications  =
 +
| onset          = Adolescence
 +
| duration        = Long term
 +
| types          = FSHD1, FSHD2
 +
| causes          = Genetic (inherited or new mutation)
 +
| risks          =
 +
| diagnosis      = Genetic testing
 +
| differential    = [[Limb-girdle muscular dystrophy]] (especially LGMD2A), [[Pompe disease]], [[Mitochondrial myopathy]], [[Polymyositis]]
 +
| prevention      =
 +
| management      = Physical therapy, bracing, orthopedic surgery
 +
| medication      =
 +
| prognosis      =
 +
| frequency      = 1 in 8333 to 1 in 15000
 +
| deaths          =
 
}}
 
}}

Latest revision as of 16:38, 29 January 2021